Status:
COMPLETED
COVID-19 and Vitamin D: Length of Hospital Stay and Mortality
Lead Sponsor:
Yuksek Ihtisas University
Collaborating Sponsors:
Ankara City Hospital Bilkent
Conditions:
COVID-19 Pandemic
Vitamin D Deficiency
Eligibility:
All Genders
18+ years
Brief Summary
The lack of a pharmacological treatment in the COVID-19 pandemic has pushed scientists to search for this issue. Maintaining optimal health is parallel to adequate and balanced nutrition. In this cont...
Detailed Description
This research was conducted to examine the effect of vitamin D on mortality and hospital stay in COVID-19 disease. For this, the approval of the Ministry of Health and then the ethics committee was ob...
Eligibility Criteria
Inclusion
- COVID-19 PCR (Polymerase Chain Reaction) test positive
- Vitamin D level in biochemical parameters
- Adult patients hospitalized for COVID-19
Exclusion
- Patients using drugs that may affect vitamin D absorption, such as corticosteroids, cholesterol-lowering agents, phenobarbital and phenytoin-containing agents
Key Trial Info
Start Date :
August 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 16 2021
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT05221983
Start Date
August 21 2021
End Date
November 16 2021
Last Update
February 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Republic of Turkey Ministry of Health Ankara City Hospitals Neurology-Orthopedics Hospital
Ankara, Turkey (Türkiye), 06800